BME en Bolsa

Pues ayer acabó en mínimos intradía. Y tiene toda la pinta de querer seguir bajando.

Por eso yo estoy esperando, mi idea es entrar en 28x pero el indice está oscilando muy raro y si el ibex cae de 10000 creo que puede perder los 28.

Por debajo de 28 debería ser un plan perfecto y sin fisuras, veremos como va la incertidumbre, el rally de diciembre para que sigue esperando.

Tranquilo, yo tengo una orden a poco más de 28 pavos y como me entre seguro que se desploma a 25 por lo menos. Jajajá. Nunca falla. Siempre que compro algo ese algo que se va a visitar los infiernos. Jajajá. Eso sí, ciertamente por debajo de 28 es un muy buen precio pero prefiero entrar ya y seguir promediando. BME es para mi jubilación.

Suerte y saludos.

Fuera de BME -3%. Me huele fatal y más MiFID II, la directiva sobre los mercados financieros entra en vigor en enero

¿Pero el MiFID II y la plataforma de fondos no eran buenas noticias a caso? ¿O lo he interpretado mal?

la ley de la bolsa es entrar cuando hay sangre y yo sigo ampliando,el que se acojone en esto no vale para la bolsa hay que comprar cuando hay sangre asi nunca llegareis a ricos,animo y suerte

¿Sangre? ¿Con el Ibex por encima de los 10.000 puntos? ¿Con BME por encima de 27?.....

La sangre es cuando BME esté a 17 euros, el IBEX a 7000, y se hable de la quiebra mundial. No faltará mucho, el "apocalipsis del retail" está a la vuelta de la esquina, y posiblemete nos meta de lleno en otra gran recesión. En ese momento habrá sangre. Esto no son ni "rozaduras".

08 Nov 2017 Euronext publishes third quarter 2017 results Results driven by volume growth and the contribution from new acquisitions Amsterdam, Brussels, Lisbon, London and Paris – 8 November 2017 - Today Euronext announced its results for the third quarter of 2017. Strong revenue growth in Q3 2017, up +14.1%[1] compared to Q3 2016, to €128.7m, mainly due to: Improvement of volumes in a stabilised macro environment: Cash average daily volume (ADV) up +19.5% in Q3 2017 compared to Q3 2016, to €6.9bn Market share of cash equities strengthened to 65.2%, with robust yield Improved competitive landscape for Dutch derivatives with equity derivatives ADV up +20.8% Strong listing activity over the quarter, with increases in IPO (+68.6%) and follow-on (+38.2%) revenue Deployment of Agility for Growth initiatives (€2.9m of revenue): development of Corporate Services activity through the acquisition of iBabs in July 2017 Positive impact of the acquisition of FastMatch (€2.9m of revenue[2]), with spot FX ADV up +49.5% to $18.3bn Cumulated costs savings since 1 April 2016 of €11.9m at the end of Q3 2017, slightly down compared to Q2 2017 due to the costs related to Optiq® and MiFID II projects Growth of EBITDA, up +13.3%, to €69.5m (EBITDA margin of 53.9%, -0.5 points vs. Q3 2016) Net profit stable (+0.6%) at €38.3m, with good operating performance offset by exceptional items of -€9.7m, mainly related to break-up fee, one-off pension costs and advisory costs Signing of a 10-year agreement with LCH SA for financial and commodities derivatives clearing, and the swap of a 2.3% minority stake in LCH Group with a 11.1% stake with a pre-emption right[3] in LCH SA (to be closed in the next few months) Stéphane Boujnah, CEO and Chairman of the Managing Board of Euronext NV., said: “Euronext’s results for the third quarter of 2017 were driven by the improvement of volume in a stabilised macro environment and by the first contributions of our new acquisitions. We ensured a +13.3% growth in EBITDA this quarter, while we pursued major projects such as MiFID II and Optiq®. This quarter was marked by the deployment of our Agility for Growth strategic plan, through the acquisition of iBabs in July, and by the closing of the acquisition of FastMatch in August. Another major milestone was met in August when we secured the renewal of a 10-year agreement for derivatives clearing with LCH SA, as well as a 11.1% stake and a pre-emption right in this company, ensuring a long-term and improved value proposition for our customers and investors.”

http://www.euronext.com/en/news/euronext-publishes-third-quarter-2017-results